Orthovita shareholders sue over proposed Stryker merger; Hatch Medical expands Israeli activities;

> Shareholders of Orthovita are suing over a proposed $316 million merger by Stryker that represents a hefty percent premium on VITA stock price. News

> Hatch Medical, a medical device incubator and technology brokerage firm, has expanded its activities in the Israeli medical device industry. In an effort to offer its unique incubator model to Israeli medical device entrepreneurs and its brokerage services to established companies, Hatch Medical has partnered with Aaron Feldman, an Israel-based medical device executive. Hatch Medical release

> San Clemente, CA-based heart devicemaker Cameron Health plans to use $107 million from a recent round of venture capital to complete a U.S. clinical trial, boost overseas sales and expand manufacturing here. Item

> Bovie Medical has entered into an exclusive agreement with Medical Illumination International in San Fernando, CA to bring a new generation of medical lighting to the medical community in the U.S. Bovie Medical release

> Marking its first formal venture in China, the University of Pittsburgh Medical Center today announced it had reached a three-year agreement with China's largest independent medical diagnostic laboratory to provide second-opinion pathology consultations. Report

And Finally... An Arkansas coroner says three tote boxes seized last year that contained human heads and other body parts will be cremated. Authorities seized the body parts stored in containers last June at Little Rock National Airport. The Arkansas Democrat-Gazette reports that a Wynne consulting group was moving the containers to a facility in Fort Worth, Texas, operated by Medtronic. News

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.